Feedback of Individual Genetic Results to Research Participants: Is It Feasible in Europe?
Bentzen, Heidi Beate
Harris, Jennifer R.
Article (Published version)
MetadataShow full item record
Background: There is growing consensus that individual genetic research results that are scientifically robust, analytically valid, and clinically actionable should be offered to research participants. However, the general practice in European research projects is that results are usually not provided to research participants for many reasons. This article reports on the views of European experts and scholars who are members of the European COST Action CHIP ME IS1303 (Citizen's Health through public-private Initiatives: Public health, Market and Ethical perspectives) regarding challenges to the feedback of individual genetic results to research participants in Europe and potential strategies to address these challenges. Materials and Methods: A consultation of the COST Action members was conducted through an email survey and a workshop. The results from the consultation were analyzed following a conventional content analysis approach. Results: Legal frameworks, professional guidelines,... and financial, organizational, and human resources to support the feedback of results are largely missing in Europe. Necessary steps to facilitate the feedback process include clarifying legal requirements to the feedback of results, developing harmonized European best practices, promoting interdisciplinary and cross-institutional collaboration, designing educational programs and cost-efficient IT-based platforms, involving research ethics committees, and documenting the health benefits and risks of the feedback process. Conclusions: Coordinated efforts at pan-European level are needed to enable equitable, scientifically sound, and socially robust feedback of results to research participants.
Source:Biopreservation and Biobanking, 2016, 14, 3, 241-248
- Mary Ann Liebert, Inc, New Rochelle
- Wellcome Trust - 096599/2/11/Z
- EU F7 project BIOSHARE
- Innovative Medicines Initiative project BTCure - 115142-1
- Biobank Standardisation and Harmonisation for Research Excellence in the European Union (BioSHaRE-EU) program - European Union Seventh Framework Programme - 261433
- European Union Seventh Framework Programme - 305444
- BioBanking and Molecular Resource Infrastructure of Sweden project - Swedish Research Council (BBMRI) LPC - 313010
- European Research Council - 648608
- EU COST Action
- Biobank Norway - Norwegian Research Council - NFR 197443/F50
- LegRegPCM (Legal Regulation of Information Processing relating to Personalized Cancer Medicine) - Norwegian Research Council - NFR BIOTEK2021/238999/O30
- National Research and Innovation Platform for Personalized Cancer Medicine - Norwegian Research Council - NFR BIOTEK2021/ES495029